Basit öğe kaydını göster

EFFICACY OF APREMILAST IN THE TREATMENT OF ORAL ULCERS OF BEHCET'S SYNDROME: RESULTS FROM THE EUROPEAN SUBGROUP OF RELIEF

dc.contributor.authorZouboulis, C. C.
dc.contributor.authorMahr, A.
dc.contributor.authorHatemi, G.
dc.contributor.authorTakeno, M.
dc.contributor.authorCheng, S.
dc.contributor.authorYazici, Y.
dc.contributor.authorChen, M.
dc.contributor.authorParis, M.
dc.contributor.authorJardon, S.
dc.contributor.authorRichter, S.
dc.contributor.authorKim, D.
dc.contributor.authorMelikoglu, M.
dc.contributor.authorSaadoun, D.
dc.date.accessioned2021-12-10T12:55:34Z
dc.date.available2021-12-10T12:55:34Z
dc.identifier.citationMahr A., Hatemi G., Takeno M., Kim D., Melikoglu M., Saadoun D., Zouboulis C. C. , Cheng S., Richter S., Jardon S., et al., "EFFICACY OF APREMILAST IN THE TREATMENT OF ORAL ULCERS OF BEHCET'S SYNDROME: RESULTS FROM THE EUROPEAN SUBGROUP OF RELIEF", ANNALS OF THE RHEUMATIC DISEASES, cilt.80, ss.349-350, 2021
dc.identifier.issn0003-4967
dc.identifier.otherav_e20a23bc-916d-453f-9183-c7a1a2f2a6d3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/174997
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2021-eular.2591
dc.language.isoeng
dc.subjectRheumatology
dc.subjectTıp
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectKlinik Tıp (MED)
dc.subjectHealth Sciences
dc.titleEFFICACY OF APREMILAST IN THE TREATMENT OF ORAL ULCERS OF BEHCET'S SYNDROME: RESULTS FROM THE EUROPEAN SUBGROUP OF RELIEF
dc.typeMakale
dc.relation.journalANNALS OF THE RHEUMATIC DISEASES
dc.contributor.departmentCantonal Hosp St Gallen , ,
dc.identifier.volume80
dc.identifier.startpage349
dc.identifier.endpage350
dc.contributor.firstauthorID2735562


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster